Research by Mads Daugaard, a UBC professor of urologic science, was featured in Express U.K.
Daugaard found that a new drug made from a malaria protein was shown to stop the growth of chemotherapy-resistant bladder cancer.
A similar story also appeared on Roundhouse Radio.